Your browser doesn't support javascript.
loading
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer.
Ouyang, Xuenong; Shi, Meiqi; Jie, Fangwei; Bai, Yuxian; Shen, Peng; Yu, Zhuang; Wang, Xiuwen; Huang, Cheng; Tao, Min; Wang, Zhehai; Xie, Conghua; Wu, Qi; Shu, Yongqian; Han, Baohui; Zhang, Fengchun; Zhang, Yiping; Hu, Chunhong; Ma, Xitao; Liang, Yongjie; Wang, Anlan; Lu, Bing; Shi, Yi; Chen, Jinfei; Zhuang, Zhixiang; Wang, Jiejun; Huang, Jianjin; Wang, Changhui; Bai, Chunxue; Zhou, Xin; Li, Qiang; Chen, Feng; Yu, Hao; Feng, Jifeng.
Afiliação
  • Ouyang X; Department of Medical Oncology, Fuzhou General Hospital of Nanjing Military Command, Fuzong Clinical College, Fujian Medical University, Fuzhou, China.
  • Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University affiliated Cancer Hospital, No.42 Baiziting, Xuanwu District, Nanjing, Jiangsu,, 210009, China.
  • Jie F; Department of Medical Oncology, Fuzhou General Hospital of Nanjing Military Command, Fuzong Clinical College, Fujian Medical University, Fuzhou, China.
  • Bai Y; Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Shen P; Department of Medical Oncology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Yu Z; Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Wang X; Department of Chemotherapy, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Huang C; Department of Medical Oncology, Fujian Provincial Cancer Hospital, The Teaching Hospital of Fujian Medical University, The Teaching Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • Tao M; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Wang Z; Department of internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
  • Xie C; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
  • Wu Q; Department of Oncology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
  • Shu Y; Department of Oncology, Jiangsu Proving Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Han B; Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhang F; Department of Oncology, Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, China.
  • Hu C; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Ma X; Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
  • Liang Y; Department of Respiratory Medicine, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Wang A; Department of Medical Oncology, Hunan Cancer Hospital, Changsha, Hunan, China.
  • Lu B; Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Shi Y; Department of Respiratory Medicine, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu, China.
  • Chen J; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhuang Z; Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Wang J; Department of Medical Oncology, Changzheng Hospital, Shanghai, China.
  • Huang J; Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Wang C; Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
  • Bai C; Department of Respiratory Medicine, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
  • Zhou X; Department of Respiratory, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Li Q; Department of Respiratory Medicine, Changhai Hospital, The Second Military Medical University, Shanghai, China.
  • Chen F; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Yu H; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Feng J; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University affiliated Cancer Hospital, No.42 Baiziting, Xuanwu District, Nanjing, Jiangsu,, 210009, China. fjifeng@126.com.
Invest New Drugs ; 36(2): 315-322, 2018 04.
Article em En | MEDLINE | ID: mdl-29134432
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Ligante Indutor de Apoptose Relacionado a TNF / Vinorelbina / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Carcinoma Pulmonar de Células não Pequenas / Ligante Indutor de Apoptose Relacionado a TNF / Vinorelbina / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article